Weight Loss Peptide GLP-1 Retatrutide 99% Purity Peptides

Retatrutide is a next-generation research peptide designed to support studies in weight loss, fitness, and metabolic balance. It is supplied as a lyophilized powder in multiple vial dosages: 5mg, 10mg, 20mg, 30mg, and 40mg, offering flexibility for various research applications and dosage protocols.

This peptide functions as a multi-receptor agonist, believed to activate GLP-1, GIP, and other key pathways involved in appetite suppression, glucose regulation, and fat metabolism. Research has shown that Retatrutide may help reduce food intake, promote fat burning, and enhance energy expenditure, making it a promising compound for combating obesity and metabolic disorders.

Our Retatrutide lyophilized powder is produced under strict GMP conditions, with purity ≥98%, ensuring consistency and reliability. It is ideal for storage, transportation, and reconstitution using sterile water or buffer before use.

Available vial sizes allow for customized dosing across different research protocols—from small animal studies to larger-scale preclinical trials.

Our Retatrutide peptide is manufactured under strict Good Manufacturing Practice (GMP) conditions, ensuring purity ≥98% and minimal endotoxin levels. It is intended exclusively for laboratory, preclinical, and clinical development use. Common research applications include:

(1) Obesity and Metabolic Syndrome Models: Investigating Retatrutide’s effects on weight reduction, fat oxidation, and energy balance in rodent or primate studies.

(2) Glucose Regulation Studies: Examining improvements in glycemic control, insulin secretion dynamics, and pancreatic β‑cell function.

(3) Appetite and Feeding Behavior Research: Assessing changes in food intake patterns, satiety responses, and neuroendocrine signaling.